Dydrogesterone: metabolism in man.
Europ. J. Drug Metab. and Pharm. 5 (1980) 173-184.
H.M. Ruijten, P.H. van Amsterdam, H. de Bree.
Qualitative ion-pair reversed-phase thin-layer chromatography.
J. Chromatogr. 252 (1982) 193-208.
H de Bree, P.H. van Amsterdam, D.J.K. van der Stel, M.Th.M. Tulp, W.R. Vincent and L.W. de Zoeten
Assay of secoverine and active metabolites; comparison of stable isotope dilution and receptor binding assay.
Pharmaceutisch Weekblad Scientific edition 5 (1983) 339.
H.M. Ruijten, P.H. van Amsterdam, H. de Bree, M.P. van Berkel, W.R. Vincent.
Development and application of an HPLC-preconcentration device capable of processing dL-amounts of (biological) sample.
Pharmaceutisch Weekblad Scientific edition 5 (1983) 340.
H.M. Ruijten, P.H. van Amsterdam, H. de Bree.
Conical precolumn as loading buffer for the main column.
J. Chromatogr. 314 (1984) 183-191.
H.M. Ruijten, P.H. van Amsterdam, H. de Bree.
Development and application of an HPLC pre-concentration device suitable for large amounts of biological sample.
In: E. Reid (ed) "Drug determination in therapeutic and forensic context" page 65-70.
1984 Plenum Publishing Corporation.
H. de Bree, P.H. van Amsterdam, D.J.K. van der Stel, M.Th.M. Tulp, W.R. Vincent and L.W. de Zoeten.
Assay of secoverine and active metabolites; comparison of stable isotope dilution with receptor binding assay.
In: E. Reid (ed) "Drug determination in therapeutic and forensic contexts" page 305-310. 1984: Plenum Publishing Corporation.
Henry M. Ruijten, Peter H. van Amsterdam and Hans de Bree
The use of conical precolumns in chromatographic analysis
Trends in Analytical Chemistry, vol 6, no. 5, 1987
H.M. Ruijten, H. de Bree, P.H. van Amsterdam
The use of conically shaped precolumns in chromatographic analysis
Pharmaceutisch Weekblad Scientific Edition 10 (1988) 65
A. Michael, N. de Jaeger, R. Sneyers, W. De Wispelaere, E. Geladé, J. Kern, W. Gorter, P. van Amsterdam, Y. Den Tandt, E. Houtmeyers, L. Van Cothem.
Influence of Porosity on the Electrical Sensing Zone and Laser Diffraction Sizing of Silicas. A Collaborative Study.
Part. Part. Syst. Charact. II (1994) 391-397.
J.A.M. Berk, A. Van der Laan, A. Wolthuis, L.J. Oppenheimer, G. Hommema, M.G.C. Van der Hart, M.B. Hesselink, P.H. van Amsterdam and E. Fuchs
Norepinephrine detection in “Tree Shrews” urine using LC-Tandem MS to verify that stress-induced alterations are prevented by the NK1 receptor antagonist SLV 323
Ned Tijdschr Klin Chem Labgeneesk 2004; 29: 269-270
Berthold Lausecker, Peter van Amsterdam, Margarete Brudny-Kloeppel, Silke Luedtke, Philip Timmerman
European Bioanalysis Forum and the way forward towards harmonized regulations
Bioanalysis (2009) 1(5) 873-875
Philip Timmerman, Silke Luedtke, Peter van Amsterdam, Margarete Brudny-Kloeppel, Berthold Lausecker
Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum
Bioanalysis (2009) 1(6) 1049-1056
Natasha Savoie, Fabio Garofolo, Peter van Amsterdam, Brian P Booth, Douglas M. Fast, Michael Lindsay, Steve Lowes, Robert Masse, Louise Mawer, Eric Ormsby, Rupinder Phull, Mario L Rocci Jr, Patrick T. Vallano, Xia Yin
The 3rd Calibration and Validation Group Workshop on Recent Issues in Regulated Bioanalysis
Bioanalysis (2010) 2(1) 53-68
Peter van Amsterdam, Berthold Lausecker, Silke Luedtke, Philip Timmerman, Margarete Brudny-Kloeppel
Towards harmonized regulations for bioanalysis: moving forward!
Bioanalysis (2010) 2(4) 689-691
Peter van Amsterdam, Mark Arnold, Surendra Bansal, Douglas Fast, Fabio Garofolo, Philip Timmerman, Eric Woolf
Global Bioanalysis Consortium – Working towards a functional globally acceptable and harmonized guideline on bioanalytical method validation
Bioanalysis (2010) 2(11), 1801-1803
Peter van Amsterdam, Clare Waldrop
The application of dried blood spot sampling in global clinical trials
Bioanalysis (2010) 2(11) 1783-1786
Natasha Savoie, Fabio Garofolo, Peter van Amsterdam, Surendra Bansal, Chris Beaver, Patrick Bedford, Brian P Booth, Christopher Evans, Mohammed Jemal, Marc Lefebvre, Arthur Leonardo Lopes de Silva, Steve Lowes, Joseph Marini, Robert Masse, Louise Mawer, Eric Ormsby, Mario L Rocci Jr, CT Viswanathan, Jason Wakelin-Smith, Jan Welink, Joleen White, Eric Woolf
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Regulations - from The 4th Calibration and Validation Group Workshop
Bioanalysis (2010) 2(12), 1945-1960
Richard W. Abbott, Ben Gordon, Peter van Amsterdam, Berthold Lausecker, Magarete Brudny-Kloeppel, John Smeraglia, Fernando Romero, Susanne Globig, Michaela Golob, Magnus Knutsson, Christian Herling, Eva Vieser, Philip Timmerman
Conference report: “From Challenges to Solutions”
Bioanalysis (2011) 3(8), 833-838
Fabio Garofolo, Mario L Rocci, Isabelle Dumont, Suzanne Martinez, Steve Lowes, Eric Woolf, Peter van Amsterdam, Surendra Bansal, Ariadna Cristina Gomes Barra, Ronald Bauer, Brian P Booth, Montserrat Carrasco-Triguero, Binodh DeSilva, John Dunn, Keith Gallicano, Dominique Gouty, Stacy Ho, Richard Hucker, Mohammed Jemal, Noriko Katori, Olivier Le Blaye, Jean Lee, Wenkui Li, Steve Michael, Corey Nehls, Robert Nicholson, Eric Ormsby, Daniel Tang, CT Viswanathan, Russell Weiner, Graeme Young
2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections
Bioanalysis, (2011) 3(18), 2081-2096.
Carl Johan Sennbro, Magnus Knutsson, Philip Timmerman and Peter van Amsterdam
Anticoagulant counter ion impact on bioanalytical performance – additional validation required?
Bioanalysis (2011) 3(21) 2389-2391
Carl Johan Sennbro, Magnus Knutsson, Peter van Amsterdam and Philip Timmerman
Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum
Bioanalysis (2011) 3(21) 2393-2399
Shinobu Kudoh, Philip Timmerman, Peter van Amsterdam, Mark Arnold, Fabio Garofolo, Shrinivas Savale, Michaela Golob, Binodh DeSilva, Daniel Tang, Rafael Barrientos
Global Harmonization on Regulated Bioanalysis and Global Bioanalysis Consortium: a historic perspective on the evolution of Regulated Bioanalysis since 1990 and why Globalization requires Harmonization.
Pharm Tech Japan 2012, Vol. 28, No. 3 489-499
Mark E. Arnold, Rafael E. Barrientos-Astigarraga, Fabio Garofolo, Shinobu Kudoh, Shrinivas S. Savale, Daniel Tang, Philip Timmerman, Peter van Amsterdam
Current regulations for bioanalytical method validations
In Wenkui Li (ed), Jie Zhang (ed), Francis LS Tse (ed)
Handbook of LC-MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations, 39-46
John Wiley & Sons, 2013, Hoboken NJ, USA
Philip Timmerman, Berthold Lausecker, Begona Barossa, Peter van Amsterdam, Silke Luedtke and Jessica Dijksman
Conference report from the European Bioanalysis Forum Open Meeting – ‘Large meets Small’ on connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS)
Bioanalysis (2012) 4(6) 627-631
Jessica Dijksman, Philip Timmerman, Richard Abbott, Begona Barroso, Margarete Brudny Kloeppel, Arjen Companjen, Michaela Golob, Ben Gordon, Christian Herling, Magnus Knutsson, Silke Luedtke, Birgitte Buur Rasmussen, Daniela Stoellner, Eva Vieser, Graeme Young, Peter van Amsterdam
Conference report from the European Bioanalysis Forum Open Meeting: Less is More – Defining modern Bioanalysis
Bioanalysis (2012) 4(6) 633-642
Jessica Dijksman, Neil Henderson, Benno Ingelse, Hans Mulder, John Smeraglia, Philip Timmerman, Margarete Brudny-Kloeppel, Arjen Companjen, Peter van Amsterdam
Conference Report on the 3rd EBF Focus Meeting “Hatching” - Emerging technologies approaching the regulated bioanalysis laboratory
Bioanalysis (2012) 4(23), 2769-2774
Peter van Amsterdam, Arjen Companjen, Margarete Brudny-Kloeppel, Michaela Golob, Silke Luedtke & Philip Timmerman
The EBF community’s evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation
Bioanalysis (2013) 5(6), 645-659
Mélanie Bergeron, Annik Bergeron, Peter van Amsterdam, Milton Furtado and Fabio Garofolo
Use of Polarity Switching for the Simultaneous Bioanalysis of Analytes Having Three Orders of Magnitude Difference in Concentration by LC-MS/MS
Bioanalysis (2013) 5(15), 1911-1918
John Smeraglia, Stuart McDougall, Karen Elsby, Arjen Companjen, Stephen White, Michaela Golob, Margarete Brudny-Kloeppel, Peter van Amsterdam and Philip Timmerman
Discussions during the joint AAPS and FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation – Feedback from the EBF.
Bioanalysis (2014) 6(6), 729-732
Philip Timmerman, Mark Arnold, Binodh DeSilva; Fabio Garofolo, Michaela Golob, Peter van Amsterdam, Shinobu Kudoh; Puran Singhal, Daniel Tang; Maria Francesca Riccio, Rafael Barientos, Shrivias Saval and Tatsuo Kurokawa
Introduction to the proposals from the Global Bioanalysis Consortium Harmonization Team discussions
The AAPS Journal (2014) Published online DOI: 10.1208/s12248-014-9609-4
Anneke Winsemius, Jean-Claude Ansquer, Matthias Olbrich, Peter van Amsterdam, Patrick Aubonnet, Katrin Beckmann, Stefan Driessen, Hanneke van Assche, Gabi Piskol, Dirk Lehnick, Katsuhiro Mihara
Pharmacokinetic interaction between simvastatin and fenofibrate with staggered and simultaneous dosing: does it matter?
J Clinical Pharmacology (2014) April 1
Stephen White, Neil Adcock, Walid Elbast, Jim Hiller, Magnus Knutsson, Berthold Lausecker, Jeff Long, Stuart McDougall, Fabrice Salavert, Timothy Sangster, Tom Verhaeghe, Peter van Amsterdam
European Bioanalysis Forum ‐ Recommendation on Dealing with Internal Standard Variability
Bioanalysis (2014) 6(20), 2767-2774
Peter van Amsterdam, Margarete Brudny-Kloeppel
Foreword Special Focus Issue on Special Populations: Special bioanalysis for special populations?
Bioanalysis (2014) 6(23), 3069-3071
Martijn Hilhorst, Peter van Amsterdam, Katja Heinig, Elke Zwanziger, Richard Abbott.
Stabilization of clinical samples collected for quantitative bioanalysis – practical considerations and recommendations from the European Bioanalysis Forum
Bioanalysis (2015) 7(3), 333-343
No comments:
Post a Comment